Английская Википедия:Binaytara Foundation
Шаблон:Short description Шаблон:Infobox organizationThe Binaytara Foundation (BTF) was established in 2007 by Dr. Binay Shah and wife Tara Shah with the goal of promoting health and education in underprivileged societies.[1] The BTF is a Washington State nonprofit organization exempt from taxation pursuant to Section 501(c)(3) of the Internal Revenue Code.Шаблон:Update inline[2] BTF has founded multiple programs in underdeveloped and developing countries to improve access to healthcare. Recent accomplishments include building a 25-bed cancer hospital in Nepal in 2018 and breaking ground on their new 200-bed facility in 2022.
Current projects
Upcoming Conferences of 2023:
2023 Wisconsin Multiple Myeloma & Lymphoma Summit: August 26, 2023 This CME-accredited activity features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.
2023 ANNUAL SUMMIT ON HEMATOLOGIC CANCERS: INCORPORATION OF NOVEL THERAPIES IN CLINICAL PRACTICE: September 15 - 17, 2023 This CME-accredited activity features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, multiple myeloma, and lymphoma. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances along with case-based discussion in the field of hematologic malignancies. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.
2023 CANCER IMMUNOTHERAPY SUMMIT: EVERYTHING, EVERYWHERE, ALL AT ONCE OF CANCER IMMUNOTHERAPY: September 22 & 23, 2023 This CME-accredited conference features leading experts in the field who will provide a comprehensive overview of current and emerging strategies to integrate immunotherapy in the management of cancers. These experts will offer their insights on mechanisms of immunotherapy toxicity, host factors regulating efficacy and resistance, and neoadjuvant immunotherapy, all in the pursuit of improving patient outcomes. This activity aims to enhance learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to incorporate immunotherapy and optimize clinical outcomes for cancer patients. The oncology conference will use a mix of didactic lectures and case-based panel discussions to highlight areas of debate in the field of immuno-oncology. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to contribute effectively to patient care.
2023 ANNUAL SYMPOSIUM FOR EVOLVING THERAPIES AND DRUG DEVELOPMENT IN ONCOLOGY: TARGETED THERAPY, IMMUNOTHERAPY AND BEYOND: September 29 & 30, 2023 A two-day conference aimed at improving the knowledge and competence of academic and community oncology providers on the biomarker-guided treatment of cancer, and design and conduct of clinical trials in the era of novel therapies. The activity will use a mix of didactic lectures and panel discussions to highlight various aspects of precision oncology, including current challenges and opportunities in designing clinical trials in the era of novel therapies.
2023 MIDWEST PRECISION ONCOLOGY SYMPOSIUM: September 30, 2023 This program, the 2023 Midwest Precision Oncology Symposium, is an accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.
This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.
During this live meeting, expert faculty will review recent advances, as well as key abstract findings relevant to precision oncology from the ASCO2023 annual meeting and place those findings into clinical context during the case-based discussions and questions and answer sessions, with a focus on how those findings might impact patient care.
2023 PRECISION ONCOLOGY SUMMIT: PERSONALIZING TREATMENT TO IMPROVE PATIENT OUTCOMES: October 7 & 8, 2023 An oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2023 ASCO Annual Meeting in June 2023.
This conference will augment healthcare providers’ foundation of knowledge and clinical competence in several areas, including:
- Integrating different platforms available for testing of actionable molecular alterations for identification of targeted therapy options.
- Current and evolving paradigms in precision oncology approach for management of common malignancies.
- Trends, challenges, controversies, and cost-considerations of precision oncology approaches and targeted therapies.
SANTA FE PRECISION ONCOLOGY SYMPOSIUM: October 21, 2023 An accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.
SALT LAKE CITY PRECISION ONCOLOGY SYMPOSIUM: November 4, 2023 An accredited continuing education activity designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies. This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties.
Binaytara Foundation Cancer Center: The Binaytara Foundation opened the Binaytara Foundation Cancer Center on December 17, 2018, in Janakpur in Nepal.[3] It is the first cancer center in the region, and will provide cutting-edge treatment to patients while also serving as a hub for research and education. The center was desperately needed in the region, with the nearest cancer center a full day's drive away in Kathmandu.[4] It is the only public state-of-the-art cancer center in Nepal's Province No. 2, which is the most densely populated province in the country. The center serves a population area of about 15 million, including those from neighboring provinces and India. The Binaytara Foundation Cancer Center (BTFCC) in Janakpur, Nepal will be expanding to a 200-bed facility to help more patients by providing cutting-edge, evidence based, compassionate cancer care to patients of Madhesh and neighboring states of Nepal and India – a population of 25 million. On April 15, 2022, the Binaytara Foundation Cancer Center held a groundbreaking ceremony for the first phase of building. The new hospital is slated to be finished by 2025 and is anticipated to serve around 25,000 patients per year. [5] [6]
International Journal of Cancer Care and Delivery (IJCCD): This publication is an open-access (CC BY-SA) peer-reviewed online journal that publishes a wide range of scientific articles focused on improving the care of cancer patients by minimizing or eliminating barriers to care delivery. We invite researchers, clinicians, and innovators from anywhere in the world who have designed, implemented, or evaluated innovative systems, processes, guidelines, technologies, clinical audits and quality improvement projects to submit related articles for review and publication. The journal encourages the submission of high-quality manuscripts covering all aspects of cancer care and care delivery. [7]
COMING SOON - OncoBlast: A serious game application to educate healthcare providers about the latest developments in the field of oncology.
Past projects
The International Conference on Advances in Hematology and Oncology (ICAHO): ICAHO is an annual conference for medial professionals generally held in August of each year in Coeur d'Alene, Idaho. The conference's aim is to improve the care of hematology and oncology patients by providing attendees with new updates in the field. There are opportunities provided to submit research abstracts, with accepted abstracts appearing in the Anticancer Research Journal. Recent hashtags for the ICAHO conferences include #ICAHO2017 and #ICAHO2018. The conference agenda is geared toward the following:
- Hematologists
- Medical Oncologists
- Radiation Oncologists
- Surgeons
- Primary Care Providers (Internists, Family practitioners, NP, PA)
- Oncology Nurses
- Pharmacists
- Basic Science Researchers
- Other healthcare professionals involved in the management of cancer patients.
Northwest Cancer Summit: BTF hosts periodic free public meetings in Northwest Washington designed to educate cancer patients. The summits, called Northwest Cancer Summit: Empowering Patients and Demystifying Cancer, facilitate discussion among cancer patients, their family members, caregivers, healthcare professionals and other experts to help. Summits are held periodically within Whatcom and Skagit Counties of Washington. Speakers and topics vary by event.
Northwest Cancer Climb: This annual fundraising event takes participants with hiking to the top of Oyster Dome, a trail near Bellingham, Wash. Registered participants receive a free t-shirt and are also entered to win prizes upon reaches the summit. Proceeds benefit BTF's programs.
Medical Research Grant: With the overview of exploring the medical sciences and evidence-based practice where financial barriers restrict them, BTF awarded grants for medical research in underdeveloped and developing nations including Nepal and India.[8] The program started in 2008 and was awarded every year until 2015.[9][10]
Cervical Cancer Screening: BTF partnered with Cancer Care Nepal to develop a screening program for low- and middle-income women ages 30 to 60 who live in the rural and suburban areas of Kathmandu and Lalitpur Districts, Nepal. The cervical cancer screening program was conducted over a six-month period starting in May 2014. More than 1,000 women were screened for cervical cancer.
BTF Telemedicine Project: Using wireless video consultation, experts from the U.S. volunteered in weekly telemedicine session with physicians in Manipal College of Medical Sciences in Pokhara, Nepal, between March 2010 and March 2012.[11]
BTF Scholarship: The first project was launched March 31, 2007, when BTF distributed uniforms and stationery to 33 underprivileged students of Yog Kumar Secondary School, Blaba- Sarpallo, Mahottari, Nepal.[12] BTF scholarships were also provided to 44 school children in 2008.
BTF-UIC (University of Illinois at Chicago) Telelecture Series: The university and BTF conducted a specialty telemedicine review course in hematological malignancies to provide physicians from developing countries with information on recent advances in management.[13]
Bone Marrow Transplant Center: The bone marrow transplant (BMT) program is a joint venture between BTF, UIC Center for Global Health, University of Illinois Hospital and Health Sciences System, and the Civil Service Hospital.[14][15] They have partnered in a project to develop the first Blood and Marrow Stem Cell Transplant (BMT) Center in Nepal.[16] BTF provided financial support for the training of two physicians and a nurse from Nepal at the UIC Medical Center Chicago for this project. BTF also supported the training of one physician in clinical genetics.
Funding
Funding is acquired through grants, sponsorships, and donations.
Funding details
Шаблон:Col-beginШаблон:Col-breakFunding details as of 2018:[17] Шаблон:Col-breakШаблон:Pie chartШаблон:Col-break Шаблон:Pie chart Шаблон:Col-end
Assets
As of 2018, the Binaytara Foundation had net assets of $159,452.[17]
References
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ Шаблон:Cite web
- ↑ "Шаблон:Cite web"
- ↑ 17,0 17,1 Шаблон:Cite web
- Английская Википедия
- Страницы с неработающими файловыми ссылками
- Medical and health foundations in the United States
- Non-profit organizations based in Washington (state)
- United Nations Economic and Social Council
- Cancer organisations based in Nepal
- 2007 establishments in Nepal
- Страницы, где используется шаблон "Навигационная таблица/Телепорт"
- Страницы с телепортом
- Википедия
- Статья из Википедии
- Статья из Английской Википедии
